50ml Isotonic Saline Solution 0.9% NaCl - Inhalation Solution for Nebuliser – Reduce Mucus and Allergy Symptoms - Nebuliser Saline Solution for Humidyfing Airways

Show on Amazon

Offer

i

Price trend

Product description

  • VENTURE HEALTHCARE Hydra-Neb saline solution is manufactured in France, in a clinically hygienic environment to help maintain top quality for our nebuliser solutions. Hydra-Neb is owned by a UK-Based Pharmaceutical company, Venture Healthcare, we provide medical products to the NHS at affordable rates and are now providing the same quality service direct to the end user. Our saline for nebulisers is made with the customer in mind, helping to maintain high-quality products for general use.
  • 1 Box 50ml This version of Hydra-Neb, sodium chloride solution 0.9%, is individually packaged in 40 x 2.5ml vials per unit, keeping each dosage sterile and hygienic in between separate uses. Hydra-Neb saline water for nebulisers is manufactured with quality and hygiene in mind. These vials are packaged in a box keeping them safe and secure in delivery and store at your convenience.
  • HELPS PREVENT AGAINST LUNG ISSUES AND INFECTION Isotonic saline solution is commonly used for clearing airways, dealing with, and preventing lung issues and infections. This version of Hydra-Neb contains 0.9% sodium chloride concentration. Isotonic solutions contain similar levels of salt as your body has naturally. Both Hypertonic and Isotonic versions of saline solutions can improve mucociliary transport by thinning mucus in the airways.
  • NO INJECTION NECESSARY - A CLINICALLY SAFE METHOD Hydra-Neb nebuliser saline solution is safe for inhalation and does not require injection. NaCl 0.9% sodium chloride is meant for inhalation through a nebuliser. Our sterile saline 0.9% is regulated and proven to be effective against lung infection and other respiratory issues. Manufactured using aseptic methods in Europe. Preservative free and safe for all ages.

You might also be interested in these nebuliser bottles.

© 2025 WHICH.ONE. ALL CONTENT IS SUBJECT TO OUR COPYRIGHT.